Champlain Investment Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-573,275
Closed -$20.6M 164
2015
Q4
$20.6M Sell
573,275
-38,802
-6% -$1.4M 0.35% 106
2015
Q3
$19.6M Sell
612,077
-283,633
-32% -$9.66M 0.34% 104
2015
Q2
$30.5M Buy
895,710
+16,500
+2% +$556K 0.48% 93
2015
Q1
$29.8M Buy
879,210
+207,810
+31% +$7.24M 0.51% 88
2014
Q4
$23.6M Sell
671,400
-4,320
-0.6% -$145K 0.38% 103
2014
Q3
$22.1M Buy
675,720
+213,950
+46% +$7.28M 0.38% 106
2014
Q2
$15.7M Sell
461,770
-4,550
-1% -$156K 0.26% 121
2014
Q1
$16.3M Sell
466,320
-15,230
-3% -$537K 0.28% 118
2013
Q4
$17.6M Sell
481,550
-11,480
-2% -$421K 0.31% 113
2013
Q3
$17.1M Sell
493,030
-610
-0.1% -$21.3K 0.32% 109
2013
Q2
$16.7M Buy
+493,640
New +$16.4M 0.34% 112

Other funds holding ACH

Champlain Investment Partners's ACH Position: Q1 2016 in Review

Champlain Investment Partners sold out of Accendra Health (ACH) in Q1 2016, closing a stake of 573,275 shares — an estimated $20.6M sold.

Champlain Investment Partners first reported a position in ACH in Q2 2013 and held it in 11 quarters. The position peaked at $30.5M in Q2 2015. 286 funds tracked by Wall St. Rank hold ACH as of Q1 2016.

  • Champlain Investment Partners reported no remaining Accendra Health position as of Q1 2016 after selling out during the quarter.
  • Champlain Investment Partners sold 573,275 Accendra Health shares in Q1 2016, an estimated $20.6M.
  • Champlain Investment Partners first reported a position in Accendra Health in Q2 2013 and held it in 11 quarters.
  • Champlain Investment Partners's Accendra Health position peaked at $30.5M in Q2 2015.
  • 286 funds tracked by Wall St. Rank held Accendra Health as of Q1 2016.

Based on Champlain Investment Partners's 13F filing for Q1 2016, filed 11 May 2016.